CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma

ανά Quintás-Cardama, Alfonso
Τόπος έκδοσης Oncotarget (2018)

Molecular biology of bcr-abl1–positive chronic myeloid leukemia

ανά Quintás-Cardama, Alfonso, Cortes, Jorge
Έκδοση 2009

Bullet ‘Manicure’: Does Lead Prevent Hydroxyurea-induced Cutaneous Toxicity?

ανά Falchi, Lorenzo, Quintás-Cardama, Alfonso
Τόπος έκδοσης Jpn J Clin Oncol (2014)

MOLECULAR PATHWAYS: JAK/STAT PATHWAY: MUTATIONS, INHIBITORS, AND RESISTANCE

ανά Quintás-Cardama, Alfonso, Verstovsek, Srdan
Τόπος έκδοσης Clin Cancer Res (2013)

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans

ανά Pant, Vinod, Quintás-Cardama, Alfonso, Lozano, Guillermina
Έκδοση 2012

ADVANCES AND CONTROVERSIES IN THE DIAGNOSIS, PATHOGENESIS, AND TREATMENT OF SYSTEMIC MASTOCYTOSIS

ανά Quintás-Cardama, Alfonso, Jain, Nitin, Verstovsek, Srdan
Τόπος έκδοσης Cancer (2011)

The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome

ανά Larsson, Connie A., Cote, Gilbert, Quintás-Cardama, Alfonso
Έκδοση 2013

Investigational Immunotherapeutics for B-Cell Malignancies

ανά Quintás-Cardama, Alfonso, Wierda, William, O'Brien, Susan
Τόπος έκδοσης J Clin Oncol (2010)

Monitoring Molecular Response in Chronic Myeloid Leukemia

ανά Cortes, Jorge, Quintás-Cardama, Alfonso, Kantarjian, Hagop M.
Τόπος έκδοσης Cancer (2010)

Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia

ανά Quintás-Cardama, Alfonso, Han, Xin, Kantarjian, Hagop, Cortes, Jorge
Έκδοση 2009

Early Cytogenetic and Molecular Response During First-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase: Long-Term Implications

ανά Quintás-Cardama, Alfonso, Cortes, Jorgé E., Kantarjian, Hagop M.
Έκδοση 2011

p53 pathway dysfunction in AML: beyond TP53 mutations

ανά Post, Sean M., Kornblau, Steven M., Quintás-Cardama, Alfonso
Τόπος έκδοσης Oncotarget (2017)

Prognostic Impact of the MDM2(SNP309) Allele in Leukemia and Lymphoma

ανά Post, Sean M., Pant, Vinod, Abbas, Hussein, Quintás-Cardama, Alfonso
Έκδοση 2010

Evolution of Therapies for Chronic Myelogenous Leukemia

ανά Santos, Fabio P S, Kantarjian, Hagop, Quintás-Cardama, Alfonso, Cortes, Jorge
Έκδοση 2011

THE RISE AND FALL OF GAKEKEEPER MUTATIONS? THE BCR-ABL1(T315I) PARADIGM

ανά Gibbons, Don L., Pricl, Sabrina, Cortes, Jorge, Quintás-Cardama, Alfonso
Τόπος έκδοσης Cancer (2011)

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability

ανά Pant, Vinod, Xiong, Shunbin, Iwakuma, Tomoo, Quintás-Cardama, Alfonso, Lozano, Guillermina
Έκδοση 2011

Prognostic Model to Identify Patients With Myelofibrosis at the Highest Risk of Transformation to Acute Myeloid Leukemia

ανά Quintás-Cardama, Alfonso, Kantarjian, Hagop, Pierce, Sherry, Cortes, Jorge, Verstovsek, Srdan
Έκδοση 2013

Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis

ανά Quintás-Cardama, Alfonso, Sever, Matjaz, Cortes, Jorge, Kantarjian, Hagop, Verstovsek, Srdan
Τόπος έκδοσης Leuk Lymphoma (2013)

SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH POLYCYTHEMIA VERA

ανά Sever, Matjaz, Quintás-Cardama, Alfonso, Pierce, Sherry, Zhou, Lingsha, Kantarjian, Hagop, Verstovsek, Srdan
Έκδοση 2013

PREDICTING OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AT ANY TIME DURING TYROSINE KINASE INHIBITOR THERAPY

ανά Quintás-Cardama, Alfonso, Choi, Sangbum, Kantarjian, Hagop, Jabbour, Elias, Huang, Xuelin, Cortes, Jorge
Έκδοση 2014